questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of changes to National Institute for Health and Care Excellence guidance in May 2025 on supporting patients in accessing lateral flow tests for covid-19.
answerText: The National Institute for Health and Care Excellence (NICE) updated its recommendations on the use of nirmatrelvir plus ritonavir for the treatment COVID‑19 in adults in May 2025. The update followed a decision by the company to set a new list price for ...
heading: Coronavirus: Screening